AMG133 is a monoclonal antibody drug designed to block the glucose-dependent insulinotropic polypeptide (GIP) receptor and simultaneously bind to two modified GLP-1 peptide segments to activate the GLP-1 receptor
Wegovy | European Medicines Agency, European Medicines Agency, Accessed 20 November 2023
Non-GLP-1 alternatives If GLP-1 medications are too expensive, there are more affordable alternatives that can still help you lose weight and maintain the weight loss
According to Novo Nordisk, some of these compounded products may contain unapproved or unregulated active pharmaceutical ingredients
Both medications can also affect your central nervous system, which may lead to increased drowsiness, dizziness, or difficulty concentrating
Whether you are a student, coach, therapist, parent, teacher or simply someone seeking to improve at something, this episode provides numerous science-supported tools for how to adopt a performance enhancing mindset